Epibiotech will offer off-the-shelf allogeneic hair multiplication treatment in South Korea, using dermalpapillacells from donors to grow hair in balding areas. This method is cheaper and less invasive than traditional hair transplants.
AMP-303 and AMP-601 are new hair loss treatments targeting dermalpapillacells, with AMP-303 showing early efficacy in transitioning vellus hairs to terminal hairs after one injection. Further clinical trials are planned, and these treatments are seen as promising due to their biologic approach and less frequent application compared to daily treatments.
A study that outlines the full model for androgenic alopecia (AGA) which links DHT to cellular senescence in dermalpapillacells, and suggests black chokeberry as a source of cyanidin 3-O-arabinoside polyphenol with potential anti-oxidant properties that could reverse this process. The post encourages reaching out to experts in anti-aging and longevity to research treatments involving the polyphenol.
The conversation is about using vitamin C and Magnesium L-Threonate for hair growth by reducing DHT binding to dermalpapillacells. The original post about vitamin C's pH levels and sebum control was possibly removed by a moderator.